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ABSTRACT 
Human paraoxonase (PON1) is an enzyme associated to high-density lipoprotein 
(HDL) particles that protects against oxidative damage to both low-density 
lipoprotein (LDL) and HDL.  The enzyme is also involved in the hydrolysis of highly 
toxic metabolite from organophosphate pesticides. In the present study, the 
distribution of the PON1 polymorphisms at position -108 in the promoter region and 
at positions 55 and 192 in the coding region, in the Panamanian population (n = 187) 
was determined. The genotype of each individual was determined by PCR-RFLP. 
The genotype frequencies at position 55 were: LL 0.631, LM = 0.331, and   MM = 
0.037; frequencies at position 192 were: QQ = 0.331, QR = 0.497, and RR = 0.171; 
and the frequencies at position -108 were: CC = 0.428, CT = 0.428, and TT = 0.117. 
The highest allele frequencies were: Q = 0.581, L = 0.796 and C = 0.655. However, 
the Amerindian Panamanian group, Gnöbé Bugle, presented a low frequency for the -
108CC genotype (0.125), which might be associated to a higher risk to 
organophosphate pesticides poisoning. Arylesterase and diazoxonase activities of 
PON1 were determined in samples of the Caucasian and Black Panamanian 
population. The most frequent haplotype in the whole population was -
108CC/55LL/192QR; this haplotype was the second most frequent in Black 
Panamanians and the most frequent in Caucasian Panamanians. The arylesterase 
activities for this haplotype were 116.16 U/mL and 146.30 U/mL in Black and 
Caucasian Panamanians, respectively. Diazoxonase activities were 10.09 U/mL and 
11.25 U/mL in the same groups, respectively. Relationships between the arylesterase 
activity of PON1 and these polymorphisms are discussed. 
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RESUMEN 
La Paraoxonasa (PON1) humana es una enzima asociada a las lipoproteínas de alta 
densidad (HDL) que protege contra el daño oxidativo tanto a las lipoproteínas de 
baja densidad (LDL) como a las HDL.  La  enzima está involucrada en la hidrólisis 
de metabolitos altamente tóxicos de pesticidas organofosforados.  En el presente  
estudio, se determinó la distribución de los polimorfismos de PON1 en la posición -
108 de la región promotora y en las posiciones 55 y 192 de la región codificadora en 
la población Panameña (n=187). El genotipo de cada individuo fue determinado 
mediante PCR-RFLP. Las frecuencias genotípicas encontradas en la posición 55 
fueron: LL 0.631, LM = 0.331, y MM = 0.037;  en la posición 192: QQ = 0.331, QR 
= 0.497, y RR = 0.171; y en la posición  -108: CC = 0.428, CT = 0.428, y TT = 
0.117. Las frecuencias alélicas más altas fueron: Q = 0.581, L = 0.796 y C = 0.655. 
Sin embargo, El grupo indígena Panameño, Gnöbé Bugle, presentó una frecuencia 
baja para el genotipo  -108CC (0.125), lo que podría estar asociado a un mayor 
riesgo al envenenamiento por pesticidas organofosforados. Las actividades 
enzimáticas de PON1 arilesterasa y diazoxonasa fueron determinadas en muestras de 
la población panameña de blancos y negros. El haplotipo más frecuente en la 
población total fue -108CC/55LL/192QR; éste haplotipo fue el segundo más 
frecuente en la población Negra Panameña y el más frecuente en la población Blanca 
Panameña.  La actividad arilesterasa para este haplotipo fue de 116.16 U/mL y 
146.30 U/mL en  Negros y Blancos Panameños, respectivamente.  La actividad 
diazoxonasa fue de 10.09 U/mL y 11.25 U/mL en los grupos antes mencionados. 
Relaciones entre la actividad arilesterasa y los polimorfismos de PON1 son 
discutidos en este artículo.  
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INTRODUCTION 
Human paraoxonase (PON1) is an enzyme associated to HDL particles 
which is capable of reducing the oxidation of LDL and HDL 
components, in addition to hydrolyze highly toxic metabolites derived 
from organophosphate pesticides (Brophy et al., 2000). Several studies 
have found that PON1 acts as a protector agent against the 
development of the atherogenic plaque due to its capacity of 
hydrolyzing oxidized lipids present in the arterial wall, avoiding the 
oxidation of LDL particles (Durrington et al., 2001).  It  is well known 
that  the accumulation of oxidized  LDL  particles is one  of  the 
factors involved in heart diseases as  a consequence of development  of  
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atherosclerosis.  The enzyme is a 355 amino acid residues protein 
encoded by the PON1 gene which is located on chromosome 7q21.3-
22.1 (Furlong et al., 2006).  In humans, the enzymatic activity of 
PON1 can vary from one individual to another. This fact is due to the 
presence of a considerable amount of polymorphisms in the PON1 
gene in the coding region, as well as in the regulatory region (Furlong 
et al., 2005).  Apparently, these polymorphisms explain the differences 
observed in serum PON1 activity and serum concentration of this 
enzyme.  In the coding region, polymorphisms at positions 55 and 192 
are the most common found in individuals and they affect the 
efficiency of hydrolysis of pesticide metabolites. Polymorphism at 
position 192 generates two isoforms, Q and R, depending on the 
presence of a glutamine or arginine residue, respectively.  The product 
of the R allele is more efficient than the Q one in hydrolyzing 
paraoxon; however, the opposite is true for the hydrolysis of soman 
and sarin (Furlong et al., 2006).  Polymorphism at position 55 also 
generates two isoforms, L and M (leucine or methionine at that 
position) which is partly responsible for the differential serum levels 
observed in human PON1.  Individuals possessing the M allele present 
lower levels of this enzyme in blood. 
  
Polymorphisms in the regulatory region at position -108 affect the 
expression level of PON1 gene. Two alleles are associated to this 
position, either occurring a C or a T nucleotide. The presence of the 
allele C produces a two fold higher level of serum PON1 (Costa et al., 
2003; Furlong et al., 2005).  Apparently, the -108 polymorphism lies 
within a binding site for Sp1, a ubiquitous transcription factor common 
in TATA-less genes such as PON1. 
 
Variations in the allelic frequencies for every polymorphism of PON1 
in different populations were previously reported (Castaño et al., 2006; 
Rojas et al., 2005; Brophy et al., 2001; Holland et al., 2006).  
However, there are very few studies about the distribution of these 
polymorphisms in South- and Central-American populations despite 
the fact that the use of organophosphate pesticides is a common 
practice in the region. 
  
Taking into account the problems with organophosphate pesticides 
intoxication besides that the heart diseases are one of the most frequent 
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causes of death in Panama, we considered important to determine the 
distribution of PON1 polymorphisms at positions   - 108, 55 and 192 in 
a sample of the Panamanian population. 
 
MATERIALS AND METHODS     
Subjects 
The population sample consisted of 187 unrelated individuals (adult 
men and women) from four different racial groups: 50 Caucasian-
Panamanians, 40 Black-Panamanians, 49 Mestizos, and 48 Ngöbe-
Buglé Amerindians. Only individuals showing the representative 
phenotype of each racial group were considered. Additional criteria 
were that both parents would have the same phenotype, so that was no 
doubt about the major ancestral genetic contribution. Blood samples 
were collected by venipuncture in 5 ml tubes containing Na-EDTA. 
Every sample was conveniently identified and kept in an ice-cooled 
box until they were taken to the lab, in a period no longer than one 
hour. This research was approved by the Research National Committee 
of Bioethics (Gorgas Memorial Institute, Panama). 
  
PON1 Genotype 
The blood samples were centrifuged at 4000 rpm in a refrigerated 
centrifuge to separate the red and white blood cells from the plasma. 
The plasma was used immediately to determine the activities of PON1 
in Caucasian and Black-Panamanian subjects. DNA was isolated from 
the cell fraction either by using the Puregene DNA Purification Kit 
(Gentra Systems Inc., Minneapolis, Minnesota, USA) according to this 
manufacturer’s instructions, or by following the method described by 
Sambrook & Russel (2001) and stored at -20
o
 C until the polymorphic 
analysis. PON1 genotype at positions -108, 55 and 192 was determined 
by polymerase chain reaction followed by polymorphism specific 
restriction digestion and electrophoresis. Amplification was performed 
by using 100-200 ng of DNA, 1 U of Taq polymerase (Promega) and 
the primers (Integrated DNA technologies), in a final volume of 25 L 
(Brophy et al., 2001; Campo et al., 2004).   
 
The Primers GACCGCAAGCCACGCCTTTCTGTGCACC and 
TGAAAGACTTAAACTGCCAGTC were used to amplify PON1 -108 
polymorphic region.  The PON1 55 region was amplified with primers 
CCTGCAATAATATGAAACAACCTG and TGAAAGACTT 
AAACTGCCAGTC. Primers TATTGTTGCTGTGGGACCTGAG 
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and  GACATACTTGCCATCGGGTGAA were used to amplified 
PON1 192 polymorphic region.   A GeneAmp 2400 thermal cycler 
(Perkin-Elmer) was used to amplify the variant regions under the 
following PCR conditions: initial denaturing temperature of 96
o
 C for 
5 min, annealing temperature of 63
o
 C for 1 min (except for variant 
192 Q/R, where a temperature of 61
o
 C was used), extension 
temperature of 72
o
 C for 1 min, and then 94
o
 C for 1 min. A final 
extension temperature of 72
o
 C for 10 min was achieved for every 
determination. These conditions were repeated for 25, 30, and 30 
cycles for the PON1 -108, 55 and 192 polymorphisms, respectively. 
Aliquots of 15 L of the amplified products were digested at 37
o
 C for 
16 hours by using 1 U of the following restriction endonucleases (New 
England Biolabs): BstUI for the -108 C/T, NlaIII for the 55 L/M, and 
AlwI for the PON1 192 Q/R polymorphism.  
     
The presence of the -108C allele results in digested bands of 67 bp and 
52 bp (instead of an undigested band of 119 bp, which indicates the 
presence of a T allele). Digested bands (106 bp and 66 bp) indicated 
the presence of the M allele, whereas absence of digestion indicated 
the presence of the L allele. The R allele was determined by the 
presence of two bands; 172 bp and 66 bp and an undigested band of 
238 bp indicated the presence of the Q allele (Figure 1). 
 
 
PON1 Activities 
PON 1 enzymatic activities were only assayed in serum from 
Caucasian- and Black-Panamanian individuals by using phenylacetate 
and diazoxon as substrates (Rosenblat et al., 2003; Leary & Edwards, 
2005). There were no serum samples from Ngöbé and Mestizo groups. 
Arylesterase activity was measured by phenol production from the 
hydrolysis of 10 mM phenylacetate using 20 mM Tris-HCl, pH 8.0, 
0.9 mM CaCl2, in a total volume of 3 mL. Every determination was 
done by duplicate in a Shimatzu spectrophotometer by setting the 
apparatus in the kinetic mode at 25
o
 C. The reaction was started by 
adding the substrate.   
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Figure 1.  Agarose gels showing the PON1 polymorphisms at positions -108, 
55 and 192. 
 
 
PON1 -108 genotypes (A): M, molecular marker (100 bp DNA 
Ladder, Fermentas); CT (119, 67 and 52 bp bands); CC (67 and 52 bp 
bands) and TT (119 bp band). PON1 55 genotypes (B): M, molecular 
marker (100 bp Ladder, Invitrogen); LL (172 bp band); LM (172, 106 
and 66 bp bands); MM (data not shown). PON1 192 genotypes (C): M, 
molecular marker (100 bp DNA Ladder, Fermentas); QQ (238 bp 
band); RR (172 and 66 bp bands); and QR (238, 172 and 66 bp bands). 
 
The activity of diazoxonase was measured by pyrimidinol production 
from the hydrolysis of 1 mM diazoxon using 50 mM Tris-HCl, pH 8.0, 
1 mM CaCl2, in a final volume of 3 mL. Every measurement was also 
done by duplicate in the apparatus under the same kinetic mode at 25
o
 C.  
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PON1 Activities 
PON 1 enzymatic activities were only assayed in serum from 
Caucasian- and Black-Panamanian individuals by using phenylacetate 
and diazoxon as substrates (Rosenblat et al., 2003; Leary & Edwards, 
2005). There were no serum samples from Ngöbé and Mestizo groups. 
Arylesterase activity was measured by phenol production from the 
hydrolysis of 10 mM phenylacetate using 20 mM Tris-HCl, pH 8.0, 
0.9 mM CaCl2, in a total volume of 3 mL. Every determination was 
done by duplicate in a Shimatzu spectrophotometer by setting the 
apparatus in the kinetic mode at 25
o
 C. The reaction was started by 
adding the substrate.  The activity of diazoxonase was measured by 
pyrimidinol production from the hydrolysis of 1 mM diazoxon using 
50 mM Tris-HCl, pH 8.0, 1 mM CaCl2, in a final volume of 3 mL. 
Every measurement was also done by duplicate in the apparatus under 
the same kinetic mode at 25
o
 C. 
  
Statistical Analyses 
Data were analyzed by the Epi Info
™
 3.3.2 program. Allele and 
genotype frequencies of PON1 -108, 55 and 192 were obtained by 
direct counting. The chi-square test was used to evaluate the 
concordance of genotype frequencies with Hardy-Weinberg’s 
expectations. Differences of PON1 activities among genotypes were 
evaluated by using the capabilities of the EPIDAT program using 
Pearson test with Yates corrections. 
 
 
RESULTS 
PON 1 genotype and allele frequencies 
Genotype and allele frequencies for the PON1 polymorphisms at 
positions -108, 55 and 192, in four of the major Panamanian racial 
groups are summarized in Table 1.  A good agreement was found 
between the observed and expected genotype frequencies according to 
Hardy-Weinberg equilibrium for the whole population. However, 
when the population was segregated into racial groups, deviation from 
Hardy-Weinberg equilibrium (HWE) was observed in Caucasian 
individuals for PON1 192 genotype (

p = 0.032


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Table 1.  Genotypes and allele frequencies of PON1 polymorphisms at 
positions -108, 55 and 192 among 187 Panamanian subjects 
corresponding to the four major racial groups.  Parentheses represent 
number of individuals or alleles quantities. HWE was calculated using 




 
 
The most frequent PON1 alleles at positions -108, 55 and 192 detected 
in the whole population were C (0.655), L (0.796) and Q (0.581) 
respectively. Similarly, the most frequent genotypes were CT (0.428), 
LL (0.631) and QR (0.497). The most frequent allele at position 55 in 
each racial group was L. At position 192, Q was the most frequent in 
Caucasians, Mestizos and Ngöbés but not in Blacks. In Caucasians, 
Mestizos and Blacks, C allele at position -108, showed a higher 
frequency than the T allele, in contrast to Ngöbés where T was the 
most frequent allele.  
   
PON1 -108 
Whole 
population 
(n=187) 
Caucasian 
(n=50) 
Mestizo 
(n=49) 
Black 
(n=40) 
Ngöbé 
(n=48) 
C 0.655 0.730 (73) 0.724 (71) 0.787 (63) 0.396 (38) 
T 0.344 0.270 (27) 0.275 (27) 0.213 (17) 0.604 (58) 
CC 0.428 0.500 (25) 0.510 (25) 0.600 (24) 0.125 (6) 
CT 0.428 0.460 (23) 0.428 (21) 0.375 (15) 0.542 (26) 
TT 0.117 0.040 (2) 0.061 (3) 0.025 (1) 0.333 (16) 


 0.0136 1.360 0.296 0.606 0.839 
 
PON1  55 
L 0.796 0.750 (75) 0.796 (78) 0.775 (62) 0.864 (83) 
M 0.203 0.250 (25) 0.204 (20) 0.225 (18) 0.135 (13) 
LL 0.631 0.600 (30) 0.592 (29) 0.600 (24) 0.729 (35) 
LM 0.331 0.300 (15) 0.408 (20) 0.350 (14) 0.270 (13) 
MM 0.037 0.100 (5) 0 (0) 0.050 (2) 0 (0) 


 0.293 2.005 3.275 0.002 1.290 
 
PON1 192 
Q 0.581(217) 0.610 (61) 0.561 (55) 0.387 (31) 0.729 (70) 
R 0.419(157) 0.390 (39) 0.438 (43) 0.613 (49) 0.270 (26) 
QQ 0.331(62) 0.30 0 (15) 0.326 (16) 0.125 (5) 0.542 (26) 
QR 0.497(93) 0.620 (31) 0.469 (23) 0.525 (21) 0.375 (18) 
RR 0.171(32) 0.080 (4) 0.204 (10) 0.35 (14) 0.083 (4) 


 0.212 4.6 0.137 0.482 0.182 
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Allele frequencies among racial groups showed statistical differences 
for  PON1 192  in  Caucasians - Blacks (p=0.0048), Mestizos - Blacks  
(p=0.031), Mestizos-Ngöbés (p=0.0249) and Blacks-Ngöbés 
(p<0.0001).  At position 55, no statistical differences were observed 
among races. The allele frequency at position -108 in Ngöbés was 
statistically different from the other groups (p < 0.0001) (Table 2). 
 
Table 2. p-values obtained from alleles frequencies pairwaise 
comparison among different racial group.  The p-values correspond to 
chi square calculated using Pearson test with Yates corrections. 
 
 
 
 
PON1 -108 
 Caucasian Black Mestizo Ngöbé 
Caucasian --    
Black 0.4731 --   
Mestizo 0.9422 0.4268 --  
Ngöbé <0.0001 <0.0001 <0.0001 -- 
 
 
PON1 55 
Caucasian --    
Black 0.8298 --   
Mestizo 0.4588 0.8769 --  
Ngöbé 0.0698 0.1735 0.2941 -- 
 
 
PON1 192 
Caucasian --    
Black 0.0048 --   
Mestizo 0.5807 0.0310 --  
Ngöbé 0.1164 <0.0001 0.0249 -- 
 
Allele frequencies for the Panamanian population obtained in this 
study were compared with allele frequencies for other populations 
previously reported (Table 3).  
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Table 3. Allele frequencies of PON1 -108, 55 and 192 polymorphisms in 
different World populations compared with those found in the Panamanian 
population. 
 
 PON1 -108  PON1 55  PON1 192 
 
 Population 
 
n 
 
C 
 
T 
 
P* 
 
L 
 
M 
 
P* 
 
Q 
 
R 
 
P* 
AMERICA 
Panamaniana 187 0.66 0.34  0.80 0.20  0.58 0.42  
African-
Americansb 
117 0.85 0.15  0.0001    0.37 0.63  0.0001 
Caribbean- 
Hispanicsb 
203 0.65 0.35 0.9608    0.54 0.46 0.2826 
Costa Ricansb 518       0.757 0.243  0.0001 
Peruviansb 89 0.61 0.39 0.0501    0.539 0.461 0.4454 
Mexicansc 214 0.45 0.55 0.0650 0.84 0.16 0.1580 0.510 0.490 0.0526 
Mexican-
Mestizosb 
182       0.522 0.478 0.1294 
Canadiansb 865 0.48 0.52 0.1898    -- -- -- 
African-
Braziliansb 
70       0.471 0.529 0.0351 
European-
Braziliansb 
101       0.693 0.307 0.0101 
Caucasian-
Americansb  
82 0.38 0.62 0.0036    0.730 0.270 0.0012 
Americans-
USAb 
Washingtond 
Californiae 
376 
 
376 
260 
0.50 0.50 0.5916  
 
0.64 
0.82 
 
 
0.36 
0.18 
 
 
0.0001 
 0.5230 
0.728 0.272 
 0.0001 
Cayapa 
Indiansb (EC) 
83       0.211 0.789  0.0001 
Chileansb NS 195       0.569 0.431 0.8152 
Chileansb ES 129       0.663 0.337 0.0441 
EUROPE 
Northern 
Irishb 
170 
      
0.712 0.288 0.0003 
Englishb 282       0.710 0.290  0.0001 
Finnishb 169       0.737 0.263  0.0001 
Dutchb 250       0.716 0.284  0.0001 
Germansb 2784       0.718 0282  0.0001 
Italiansb 
(Sardinia) 
161       0.752 0.248  0.0001 
Frenchb 125       0.765 0.235  0.0001 
Spanishb 141 0.38 0.62 0.0005    0.700 0.300 0.0024 
Turkishb 381       0.692 0.308 0.0003 
ASIA 
Japaneseb 132 0.48 0.52 0.3886    0.402 0.591  0.0001 
Chineseb 475 -- -- --    0.352 0.648  0.0001 
Thaisb 202 0.25 0.75  0.0001    0.710 0.290 0.0114 
Indiansb 165       0.67 0.33 0.0173 
Indiansb ND 80       0.82 0.17  0.0001 
AFRICA 
Ethiopiansb 169       0.592 0.401 0.7954 
Benineseb 98       0.388 0.612  0.0001 
 
p*  calculated using Pearson test with Yates corrections 
aThis study. bCastaño et al. 2006, cRojas et al. 2005, dBrophy et al. 2001, eHolland et al. 2006. 
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Haplotypes and Arylesterase and Diazoxonase activities  
Arylesterase and diazoxonase activities for PON1 haplotypes in Blacks 
and Caucasians are presented in Table 4. PON1 activities revealed no 
significant differences (p>0.05) among groups for the same haplotypes. 
Individuals with haplotype -108CT/55LM/192QR had the highest 
arylesterase activity (153.25 U/mL), whereas those with haplotype 
108TT/55LM/192QR exhibited the lowest arylesterase  (48.1 U/mL) and 
diazoxonase (2.38 U/mL) activities. The highest diazoxonase activity was 
associated with the -108TT/55LM/192QQ haplotype (13.56 U/mL). The 
most frequent haplotype in the whole population was -
108CC/55LL/192QR. In Blacks, this is the second most frequent 
haplotype.  The arylesterase activities for this latter haplotype were 
116.16 U/ml and 146.30 U/mL in Blacks and Caucasians, respectively. 
Diazoxonase activities for the same latter haplotype were 10.09 U/mL and 
11.25 U/mL, in Blacks and Caucasians, respectively.  
 
Table 4. Arylesterase and Diazoxonase activities according to different  
PON1 genotypes. 
 
p0.005  evaluated by Student t-test. * Not mean values and SD (standard deviation) were calculated. 
Whole   
Popula- 
tion 
Genotype at 
Position 
Black 
(n=40) 
Caucasian 
(n=50) 
 
(n= 90) 
 
n 
 
 
-108 
 
 
55 
 
 
192 
 
 
n 
Arylesterase 
activity* 
mean (U/mL) 
± SD 
Diazoxonase  
activity*  
mean (U/mL) 
± SD 
 
 
n 
Arylesterase 
 activity* 
mean (U/mL)  
± SD 
Diazoxonase  
activity*  
mean (U/mL) 
± SD 
18 CC LL QR 6 116.16±33.75 10.09±3.97 12 146.39±3909 11.25±2.88 
12 CC LM QR 7 119.53±26.87 9.03±2.05 5 113.40±18.49 8.55±2.03 
11 CT LL QR 4 137.11±34.41 10.75±2.67 7 124.05±27.13 10.52±3.34 
7 CT LL RR 5 145.97±16.27 9.44±2.05 2 137.31±1.56 8.67±1.59 
7 CC LL RR 5 134.38  ± 40.67 9.03±2.18 2 151.18±25.30    9.5±2.85 
6 CT LL QQ 1 *95.97 *9.67 5 136 45±  20.88 13.4±2.72 
6 CT LM QR 2 153.25±1.74  13.39±1.08 4 130.62±26.94    9.09±2.56 
5 CC LL QQ 3 132.09±8.90 11.86±1.83 2 127.54±   17.74 12.53±1.45 
3 CT LM RR 3 138.07±4.96 9.76±1.25 0 -- -- 
2 TT LM QR 1 *93.83     *6.81 1 *48.10    *2.38 
2 CC MM QR 1 *126.64  *8.79 1 *129.66   *8.67 
2 CC MM QQ 1 *118.56  *9.01 1 ND -- 
2 CC LM QQ 0 -- -- 2 127.00±28.34    12.08±3.63 
2 CT MM QQ 0 -- -- 2 106.80±20.95    10.11±2.85 
2 CT LM QQ 0 -- -- 2 118.08±12.36    11.79±1.66 
1 CC LM RR 1 *149.65 *11.80 0 -- -- 
1 TT LM QQ 0 -- -- 1 *147.22    *13.56 
1 CT MM QR 0 -- -- 1 *138.7 *10.71 
 
Tejada, A. y colaboradores 46 
DISCUSSION 
To the best of our knowledge, this is the first study reporting the 
frequencies of PON1 polymorphisms at positions -108, 55, and 192 in 
the Panamanian population. The frequency of  PON1 -108C allele in 
the whole Panamanian population was considerably higher than that 
for the T allele. The frequency of the -108C allele for Panamanians 
(0.66) is higher than any other population, except for African-
Americans (0.850), and very similar to that for Caribbean-Hispanics 
(0.65) and Peruvians (0.61). This result may indicate that 
Panamanians, as well as Caribbean-Hispanics and Peruvians possess a 
relative higher plasma level of PON1, which means that these 
populations are less susceptible to organophosphate pesticide toxicity. 
The observed similarities of the C allele frequencies between 
Panamanians and other populations would be explain as a consequence 
of similar ancestral genetic contribution in the colonization period. The 
largest differences of this polymorphism were observed when we 
compared it to Thai, Caucasian American and Spanish, African 
American and Caribbean Hispanic populations (p < 0.005) (Table 3).  
 
Regarding the PON1 55 polymorphism, the L allele had the highest 
frequency in the Panamanian population (0.80), similar to Mexicans 
(0.84) and Californians (0.82). By contrast, the frequency of this allele 
was significantly higher than that observed for Washington residents 
(Holland et al., 2006).  Due to the fact that L allele has been associated 
with higher plasma PON1 levels, we expect that the Panamanian 
population is partly protected against cardiovascular disease. 
Interestingly, when we compared the frequencies of the L allele and 
percentage of mortality caused by ischemic heart disease, the countries 
with lower L allele frequencies exhibit higher percentage of mortality 
caused by this disease.  In this respect, United States has an L allele 
frequency of 0.64, having a 21 % of mortality; Panama, with a 
frequency of 0.80 for the same allele, exhibits 12 % of mortality, and 
Mexico, which the L allele frequency is 0.84, the caused of mortality 
attributed to the ischemic heart disease is 11% (World Health 
Organization. Mortality Country Fact Sheet, 2006).  
 
As indicated in Table 3, the observed frequency for PON1 192 allele Q 
in Panamanians was slightly higher (0.58) than that for Caribbean-
Hispanics (0.54) (Chen et al., 2003), Peruvians (0.54) (Cataño et al., 
2006), Mexicans (0.51) (Rojas-García et al., 2005), Mexican mestizos 
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(0.52) (Gamboa et al., 2006) and Chileans NS (0.57) (Acuña et al., 
2004). Panamanians have a relative low frequency (0.419) of the R 
allele which is associated to high arylesterase activity. The arylesterase 
activity of PON1 only provides an estimate of the sensitivity to 
organophosphate pesticides due to the fact that the arylesterase activity 
is correlated with the hydrolysis of paraoxon, which is the catabolite of 
parathion (organophaste pesticide). According to these results, we 
expect that the Panamanian population is more susceptible to 
organophosphate compounds poisoning. When we compared the 
arylesterase and diazoxonase activities among Black and Caucasian 
Panamanians, no significant differences were observed for both 
enzymes activities. This result might be explained in terms of the 
genetic complexity of the Panamanian population, which is the result 
of a mixture, not only of these two races, but also with Native-
Panamanian contribution.  
 
As mentioned before, the Panamanian population is the result of a 
mixture of several racial groups with major contributions from Native 
Americans, Blacks and Spaniards.  According to this fact, we expected 
some similarities among Panamanian racial groups and the 
corresponding ancestral groups. The frequencies for PON1 192 and 
PON1 55 alleles from Black Panamanians resemble more to that 
reported for other Black populations such as African-Americans, 
African-Brazilians and African-Benineses than the non Black 
populations.  The Panamanian Black population is descendant of the 
African Black population that arrived to the isthmus as slaves in the 
colonization period or as workers from Antilles during Panama Canal 
construction. 
  
The Panamanian Caucasian group had PON1 192 allele frequency 
more similar to the Spanish than Black African and American 
populations, including the Black Panamanian.  However, the frequency 
for the L and C alleles is quite different from that observed in the other 
Caucasian groups (Cataño et al., 2006). Unexpectedly, PON1 192 
allele frequencies for Ngöbé were very different from that reported for 
Cayapa Indians, although both groups have the same Chibchan 
linguistic origin (Kolmand & Berminghan, 1997). 
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We found that the native Panamanian group Ngöbé possesses high 
frequencies of the T and Q alleles, which make them more susceptible 
to some organophosphates poisoning. Ironically, the Ngöbé are 
primarily employed as agricultural laborers in the highlands of Panama 
where the use of organophosphate pesticides is quite high. It is well 
known that exposure  to high doses of these compounds have profound 
effects to the central nervous system, and recent evidence suggests that 
chronic low level exposure may affect neurodevelopment. This latter 
effect is important in pregnant women, newborns, and even in infants 
so that special considerations should be taken with this racial group. 
 
The highest arylesterase activity of PON1 was observed, separately, in 
individuals with -108CC, 55LL and 192 RR genotypes. Similar results 
were obtained by Rojas-García et al., (2005) in a Mexican population, 
in contrast to the results obtained by Brophy et al., (2001) in which 
individuals with PON1 192QQ genotype was associated with the 
highest arylesterase activity of PON1.  Other researchers have found 
no relationship among these genotypes and arylesterase activity of 
PON1 in Caucasian, African-American, and Caribbean populations 
(Chen et al., 2003). 
 
Arylesterase and diazoxonase activities for PON1 haplotypes in Black 
and Caucasian Panamanians are presented in Table 4. Arylesterase 
activity of PON1, as a function of different haplotypes, revealed that 
the highest arylesterase activity (151.18 U/mL) was observed in 
Panamanian Caucasian with the -108CC/55LL/192RR haplotype. This 
haplotype is generally associated with high arylesterase activiy (Rojas-
García et al., 2004).  However, these activity values are lower than 
those reported for the same haplotype in Mexicans (Rojas-García et 
al., 2004).  These differences would be explained as a consequence of 
modifications in the protocol used to measure the arylesterase activity. 
In Black Panamanians, the haplotype associated with the highest 
arylesterase activity (149.65 U/mL) was -108CC/55LM/192RR. 
Although, the arylesterase activity for the -108CC/55LL/192RR 
haplotype in Black Panamanians was lower than the -
108CT/55LM1/92QR haplotype, the obtained values may not be 
reliable because only two individuals in our study showed this 
haplotype and also  variations in the activities have been reported for 
individuals with the same haplotype (Rojas-García et al., 2004). 
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In summary, the results presented in this study represent the only 
available information so far on the frequencies of the polymorphisms 
associated to the PON1 gene in the Panamanian population.  The 
obtained allelic frequencies resemble to that reported for other Latino 
populations; however, Nögbé Bugles, an Amerindian Panamanian 
population, showed a low frequency for the -108CC genotype, which 
means that they are more susceptible to poisoning with 
organophosphate pesticides.  Besides the contribution of our study, we 
recognize the needs for more extensive studies on the relationship 
between PON1 variability and the differences in susceptibility to 
pesticide poisoning and the development of vascular diseases. 
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